Advances in the treatment of T-cell lymphoma

Prof John Gribben, Dr Myron Czuczman, Dr Randy Gascoyne, Prof Michael Pfreundschuh and Prof Wyndham Wilson
Advances in the treatment of T-cell lymphoma ( Prof John Gribben, Dr Myron Czuczman, Dr Randy Gascoyne, Prof Michael Pfreundschuh and Prof Wyndham Wilson  )
6 Dec 2011

Key research from the 9th International Workshop for Lymphoma

Professor John Gribben, Dr Myron Czuczman, Dr Randy Gascoyne, Professor Michael Pfreundschuh and Prof Wyndham Wilson
Key research from the 9th International Workshop for Lymphoma ( Professor John Gribben, Dr Myron Czuczman, Dr Randy Gascoyne, Professor Michael Pfreundschuh and Prof Wyndham Wilson  )
6 Dec 2011

Use of modified T-cells to treat advanced CLL

Prof David Porter - University of Pennsylvania, Philadelphia, USA
Use of modified T-cells to treat advanced CLL ( Prof David Porter - University of Pennsylvania, Philadelphia, USA )
24 Nov 2011

Advances in T cell lymphoma treatment

Dr Francine Foss, Prof Pier Luigi Zinzani, Prof Bertrand Coiffier, Dr Claire Dearden
Advances in T cell lymphoma treatment  ( Dr Francine Foss, Prof Pier Luigi Zinzani, Prof Bertrand Coiffier, Dr Claire Dearden )
16 Nov 2011

Highlights from day two of the 5th International Workshop

Prof Gareth Morgan (Chair) - Institute of Cancer Research, Sutton, UK; Prof Keith Stewart - Mayo Clinic, Arizona, USA; Prof Kenneth Anderson - Dana-Farber Cancer Institute Boston, MA
Highlights from day two of the 5th International Workshop ( Prof Gareth Morgan (Chair) - Institute of Cancer Research, Sutton, UK; Prof Keith Stewart - Mayo Clinic, Arizona, USA; Prof Kenneth Anderson - Dana-Farber Cancer Institute Boston, MA )
26 Oct 2011

Highlights from day one of the 5th International Workshop

Prof Gareth Morgan (Chair) - Institute of Cancer Research, Sutton, UK; Prof Keith Stewart - Mayo Clinic, Arizona, USA; Prof Kenneth Anderson - Dana-Farber Cancer Institute Boston, MA
Highlights from day one of the 5th International Workshop ( Prof Gareth Morgan (Chair) - Institute of Cancer Research, Sutton, UK; Prof Keith Stewart - Mayo Clinic, Arizona, USA; Prof Kenneth Anderson - Dana-Farber Cancer Institute Boston, MA )
26 Oct 2011

Roundup of the EMCC 2011 conference

Prof Gordon McVie - European Institute of Oncology and ecancer
Roundup of the EMCC 2011 conference ( Prof Gordon McVie - European Institute of Oncology and ecancer )
3 Oct 2011

The P-Medicine project; data sharing and integration for personalised medicine

Dr Simona Rossi - Swiss Institute for Bioinformatics, Lausanne, Switzerland
The P-Medicine project; data sharing and integration for personalised medicine ( Dr Simona Rossi - Swiss Institute for Bioinformatics, Lausanne, Switzerland )
14 Jul 2011

Ruxolitinib successfully treats myelofibrosis symptoms and improves quality of life

Dr Srdan Verstovsek - The University of Texas, MD Anderson Cancer Centre, Houston
Ruxolitinib successfully treats myelofibrosis symptoms and improves quality of life ( Dr Srdan Verstovsek - The University of Texas, MD Anderson Cancer Centre, Houston )
14 Jul 2011

Advances in the treatment of multiple myeloma

Prof Mario Boccadoro - San Giovanni Hospital, Turin, Italy
Advances in the treatment of multiple myeloma ( Prof Mario Boccadoro - San Giovanni Hospital, Turin, Italy )
14 Jul 2011

Communicating end of life options

Dr Steve Johnson – Yeovil District Hospital, UK & Prof Anton Hagenbeek - Academic Medical Centre, Amsterdam, Netherlands
Communicating end of life options ( Dr Steve Johnson – Yeovil District Hospital, UK & Prof Anton Hagenbeek - Academic Medical Centre, Amsterdam, Netherlands )
14 Jul 2011

TKI treatment for chronic myeloid leukaemia

Dr Hagop Kantarjian - MD Anderson Cancer Center, Texas, USA
TKI treatment for chronic myeloid leukaemia ( Dr Hagop Kantarjian - MD Anderson Cancer Center, Texas, USA )
14 Jul 2011